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ABSTRACT We have previously shown that the 40-residue peptide termed amyloid 13-protein (A,3P[1-40]) in solution forms
cation-selective channels across artificial phospholipid bilayer membranes. To determine whether AP3P[1-40] also forms
channels across natural membranes, we used electrically silent excised membrane patches from a cell line derived from
hypothalamic gonadotrophin-releasing hormone GnRH neurons. We found that exposing either the internal or the external
side of excised membrane patches to A,BP[1-40] leads to the spontaneous formation of cation-selective channels. With Cs'
as the main cation in both the external as well as the internal saline, the amplitude of the A,3P[1-40] channel currents was
found to follow the Cs+ gradient and to exhibit spontaneous conductance changes over a wide range (50-500 pS). We also
found that free zinc (Zn2+), reported to bind to amyloid 13-protein in solution, can block the flow of Cs+ through the A13P[1-40]
channel. Because the Zn2+ chelator o-phenanthroline can reverse this blockade, we conclude that the underlying mechanism
involves a direct interaction between the transition element Zn2+ and sites in the A13P[1-40] channel pore. These properties
of the A,BP[1-40] channel are rather similar to those observed in the artificial bilayer system. We also show here, by
immunocytochemical confocal microscopy, that amyloid 1-protein molecules form deposits closely associated with the
plasma membrane of a substantial fraction of the GnRH neurons. Taken together, these results suggest that the interactions
between amyloid 13-protein and neuronal membranes also occur in vivo, lending further support to the idea that A,BP[1-40]
channel formation might be a mechanism of amyloid 1-protein neurotoxicity.
INTRODUCTION
Alzheimer's disease (AD) is a chronic dementia affecting
the aging population and is characterized by the presence of
amyloid plaques in the brain and intraneuronal neurofibril-
lary tangles (Neve et al., 1990; Hardy and Higgins, 1992;
Selkoe, 1991). The major components of brain amyloid
plaques are peptides, 39 to 42 residues long, termed amyloid
13-proteins (Masters et al., 1985; Hass and Selkoe, 1993).
These peptides are proteolytic products of the widely dis-
tributed amyloid precursor glycoprotein (APP751), defined
by a locus on chromosome 21 (Goldgaber et al., 1987; Tanzi
et al., 1987). In particular, amyloid ,B-protein (A,BP[1-40])
has been linked to the neurotoxic principle causing neuronal
death in the disease, although the mechanism has remained
elusive (Yankner et al., 1990; Malouf, 1992; Yankner,
1992; Frazer et al., 1997).
Cortical neurons exposed to A,BP[1-40] exhibit elevated
levels of intracellular free calcium ([Ca2+]i), suggesting that
toxicity may result from amyloid 13-protein-evoked Ca2+
entry (Matson et al., 1992). We have previously shown that
when A,3P[1-40] was incorporated into lipid bilayer mem-
branes, the amyloid formed cation-selective (including
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Ca2+) channels (Arispe et al., 1993a,b; Durell et al., 1994),
and we suggested that the ability of A,BP[1-40] to form
these cation channels could be the molecular basis of amy-
loid neurotoxicity (Arispe et al., 1994). To determine
whether direct incorporation of A13P[1-40] molecules lead-
ing to channel formation might also occur in neuronal
membranes, we studied the deposit of A,BP[1-40] mole-
cules on the cell surface of cultured hypothalamic GnRH,
GT1-7, neurons by immunocytochemical techniques and
the A,BP[1-40]-channel formation in excised membrane
patches from these cells after exposure to amyloid 13-pro-
tein. We found and report here that although A,BP[1-40]
molecules can interact with the excised membrane patch
from either side, peptide incorporation leading to channel
formation was faster from the inner aspect of the excised
patch. As expected, we found that the reversal potential of
the A13P[I-40]-specific channel currents followed the Cs+
gradient, indicating that the channel was permeable to Cs+
over ClF. We also noted that the A,3P[1-40] channel in-
corporated into excised patches of GnRH neuronal mem-
brane exhibits spontaneous conductance changes over a
wide range (50-500 pS; Arispe et al., 1993a). To under-
stand the mechanism of amyloid 13-protein actions, we ex-
amined the ability of Zn2+, known to induce amyloid 13-pro-
tein aggregation (Bush et al., 1994), to bind to specific
A13P[1-40] sites (Bush et al., 1993), and to modulate
A,BP[ 1-40] channel activity in planar bilayers (Arispe et al.,
1996). We found that Zn2+ (50-500 AM) can block the
67
Volume 73 July 1997
A,BP[1-40] channel incorporated into the neuronal mem-
brane from either the external or the internal side, and the
blockade can be reversed by the addition of o-phenanthro-
line, a specific Zn2+ chelator, to the side containing Zn2+.
These properties of the Af3P[1-40] channel formed across
natural membranes are similar to those observed in artificial
bilayer membranes (Arispe et al., 1993a,b, 1996), support-
ing the idea that A,BP[1-40] channel formation might be the
mechanism of amyloid 3-protein neurotoxicity (Arispe,
1994; Frautschy et al., 1991; Kowall et al., 1992; Fuson et
al., 1996). Finally, to determine whether A,3PP[1-40] can
also interact with the plasma membrane of viable GT1-7
neurons, and to gather information on the exact localization
of A,3P[1-40] molecules, we used confocal microscopy to
localize two specific antibodies, one raised against a neu-
ronal protein marker (MAP2), and the other against A,BP[1-
40]. Both antibodies reacted with the target proteins dem-
onstrating the deposition of aggregates of AB3P[1-40] on the
surface of GT1-7 cells. From these data we conclude that
free A,3P[1-40] molecules in solution can spontaneously
interact with both intracellular and extracellular aspects of
the plasma membrane of GnRH neurons to form cation-
selective channels. In addition, our studies of Zn2+/AI3P[1-
40] channel interactions reveal that the transition element
binds to specific domains of the A,BP[1-40] channel mol-
ecules, leading to a blockade of the channel. Because the
blockade occurs when the amyloid (3-protein and Zn2+ are
added either to the same side or to opposite sides of the
membrane, these interactions could explain recent data
showing that peptide deposition and Af3P[1-40]-associated
neurotoxicity are attenuated by Zn2+ (Fuson et al., 1996;
May et al., 1996). A preliminary presentation of the data in
an abstract form has been made to the Biophysical Society
(Kawahara et al., 1996).
MATERIALS AND METHODS
Cell culture
Immortalized hypothalamic neurons (GT1-7; Mellon et al., 1990) were
cultured under conditions described previously (Mellon et al., 1990; Sper-
gel et al., 1995). Briefly, GT1-7 cells (provided by Dr. R. Weiner,
University of California at San Francisco) were grown in a mixture of 50%
Dulbecco's modified Eagle's medium and Ham's F-12 medium supple-
mented with 2.4 g/liter NaHCO3, 0.1 g/liter gentamicin, and 100 mI/liter
heat-inactivated fetal calf serum. The culture medium was changed every
2-3 days. Upon reaching confluence, the GTI-7 cells were dissociated by
incubation for 5 min at 37°C in phosphate-buffered saline containing 0.5
g/liter trypsin, 0.15 g/liter deoxyribonuclease I, 5.4 ,uM EDTA, 5.95 mM
NaHCO3, 5-6 mM glucose, and 0.07 gentamicin. The cells were then
centrifuged again, resuspended, counted, and plated in 35-mm Petri dishes
at a density of 5 X 104 cells/dish. After plating, the cells were cultured for
2-3 days before use in patch-clamp experiments.
Aj3P channel current recordings
Patch-clamp experiments were performed as previously described (Rojas et
al., 1990; Spergel et al., 1996), with minor modifications. Patch pipettes
were made from microhematocrit capillary glass by using a microcomput-
er-controlled multistep puller (BB-CH; Mecanex, Geneva, Switzerland).
Pipettes were coated to the tip with Sylgard (Dow Corning). When filled
with a Cs' solution (in mM: 140 CsCl, 0.5 CaCI2, 0.5 MgCl2, 1 EGTA, 5
NaHEPES, pH 7.4), pipette tip resistance ranged from 8 to 12 Mfl.
Channel current recordings were made with the same Cs' solution, both
inside the pipette and in the bath, by means of an EPC-7 amplifier (List
Electronics, Darmstadt, Germany). A13P[I-40] solutions were always pre-
pared fresh in distilled water. The amyloid 13-protein was added to the bath
at a concentration of -4.7 ,uM.
Membrane currents under voltage clamp conditions were recorded
through a low-pass filter set at 10 kHz (eight-pole Bessel, model 902 LPF;
Frequency Devices, Haverhill, MA) to the input amplifier of a 16-bit
resolution digital magnetic tape recorder (PCM-VCR; Unitrade, Data Ac-
quisition and Storage Systems, Philadelphia, PA).
Immunohistochemistry
GTI-7 cells were incubated for 24 h in the presence of AP3P[1-40] (-4
,.M) added to the culture medium. Next the GT1-7 cells were fixed by the
addition of paraformaldehyde (4%). After fixation cells were thoroughly
washed with medium. After this step specific antibodies against A/3P[l-
40] (c4j342; kindly donated by Dr. Mori, Tokyo Institute of Psychiatry) and
against microtubule associated protein of dividing cells (MAP2) were
added. After a prolonged exposure to the protein-specific antibodies,
secondary antibodies, conjugated to the fluorescent probes fluorescein-5-
isothiocyanate (FITC) and Texas Red, respectively, were used to identify
the presence of the proteins in the cells using a confocal microscope.
Statistical evaluation and channel
current analysis
Off-line analysis of the recorded A13P[I-40] channel activity was carried
out with the software package pClamp 5.51 (Axon Instruments, Burlin-
game, CA). Data-base files were obtained from playbacks of the experi-
mental records digitized with a 12-bit analog-to-digital converter (TL-1
DMA interface; Axon Instruments), using the Fetchex subroutine. At least
10 2048-point episodes were needed to achieve the minimum 2500 events
required to construct histograms. These data files were analyzed using the
subroutine TIP (Transit Interface Program; Baylor College of Medicine,
Houston, TX). As a rule, the data base used for the open-time and
close-time distributions corresponded to recordings with a signal-to-noise
ratio of 25:1.
Four experimental paradigms were carried out on excised inside-out
membrane patches:
Af3P[1-40] added to the bath solution
For these experiments the excised membrane patch was exposed to sym-
metrical Cs' solution for a 10-30-min period before the addition of
amyloid 13-protein. 1) After the incorporation of A13P[1-40] channel ac-
tivity, Zn2+ was added to the bath solution. 2) After the blockade by Zn2+
was apparent, the Zn2+ chelator, o-phenanthroline, was added to the bath
solution, which contained A13P[1-40] and Zn2+.
Af3P[1-40] added to the pipette solution
To allow for a control period in the absence of amyloid 13-protein, the
pipette was first back-filled with a CsCl solution. Next, a small volume
(-5 ,ll) of A,BP[1-40] water solution was added to the distal end of the
Cs' solution in the pipette. The time taken for the amyloid molecules to
reach the outer aspect of the patch allowed us to verify that the membrane
patch was electrically silent. 1) After the incorporation A13P[1-40] channel
activity, Zn2+ was added to the solution in the dish. 2) The Zn2+ chelator,
o-phenanthroline, was added to the solution in the dish after the blockade
by Zn2+ was apparent.
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Each paradigm was repeated at least three times with different cell
preparations. The figures shown are representative of the records obtained.
Chemicals and reagents
Amyloid 13-protein was obtained from Bachem California (Torrance, CA),
o-phenanthroline was from Sigma (St. Louis, MO), and ZnCl2 was from
Fluka (Ronkonkoma, NY).
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40] (extracellular side of the cell membrane), the minimum
time allowed for the control period was 5 min (see meth-
ods). For bath applications of A,BP[1-40] (intracellular side
of the cell membrane), the minimum control time was 15
min. Provided the membrane patch was electrically silent
(i.e., endogenous channel current of amplitude smaller than
0.1 pA) during this time, the amyloid (3-protein was added
to the solution in the dish to a final concentration of 4.7 ,uM.
RESULTS
To detect endogenous channels that might be present in the Af3P[1-40] but not AI8P[40-1] forms cation
.. ~channels across neuronal membranespatch, our standard protocol included an initial control pe-
riod of recording at high gain (200 mV/pA). During this Channel activity always appeared minutes after the expo-
control period the membrane potential across the patch was sure of the inner aspect of the membrane patch to A,BP[1-
held at different levels (from -40 to 40 mV) while the 40]. Records of such A,3P[1-40] channel activity incorpo-
current was recorded. For pipette applications of Af3P[1- rated from the solution into an inside-out excised patch are
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FIGURE 1 Direct incorporation of A,3P[1-40] into membrane patches from the intracellular side (bath). All records shown here were made 14-25 min
after the application of ABP[1-40] to the bath (-4.5 ,uM). (Upper left) Three sets of 10 segments of a continuous current record made at -20 mV. (Upper
right) Records made at 20 mV. Current records acquired at -40 and 40 mV are depicted at the lower left and lower right, respectively.
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shown in Fig. 1. The presence of spontaneous transitions
between different levels of the current, together with the
appearance of complete channel closures from different
levels, suggests the presence of a single channel with sev-
eral levels of conductance. Open-channel current levels as
well as open- and closed-channel kinetics were analyzed as
described previously (Arispe et al., 1996). To calculate the
fraction of time at a given conductance level from records
like those shown in Fig. 1, we obtained first open- and
closed-time histograms (not shown). The fractional open
time (estimated from records like those depicted in Fig. 1,
bottom) remained unchanged at -0.8, even though the
transmembrane potential was changed from -40 mV (left)
to 40 mV (right). By contrast, changing the potential from
-20 mV (top left) to 20 mV (top right) reduced the open
time of the channel from 0.75 to 0.25. Under the conditions
of symmetrical solutions used here (140 mM CsCl on both
sides of the membrane patch), the open-channel current was
found to be close to zero, as expected, at a transmembrane
potential of 0 mV. By contrast, in an asymmetrical CsCl
solution system (pipette: 140 mM; bath: 70 mM), the re-
versal potential was found to be about -16 mV. This is
close to the Nernst potential of -17.4 mV, assuming that
the charge carrier is Cs+. As illustrated in Fig. 1, the current
changed from positive (left) to negative (right). By contrast,
exposure of either the intracellular or the extracellular side
of the plasma membrane to the peptide AP3P[40-1] with the
reverse amino acid sequence had no effect. Indeed, mem-
brane patches (n = 6) remained electrically silent after
prolonged (30-60 min) exposures to the peptide A,BP[40-
1] (not shown).
Several traits of the ABP[I1-40] channel activity incor-
porated into artificial bilayers are also expressed in natural
membranes. These include the presence of different levels
of channel conductance, from -5 pS to 3 nS (Arispe et al.,
1993a), and the sensitivity to the transition element Zn2+
(Arispe et al., 1996), illustrated in the following section.
Interactions between Zn2+ and
AI8PCI-40] channels
We have previously shown that AfP[1-40] channels incor-
porated into artificial lipid bilayer membranes interact with
Zn2+ in a dose-dependent manner (Arispe et al., 1996). At
concentrations less than 250 ,uM, Zn2+ may induce pro-
found changes in channel kinetics, and at higher doses,
Zn2+ may even block the A,BP[1-40] channel. To deter-
mine whether the A,BP[1-40] channel activity in natural
membranes can be modulated by Zn2+, amyloid j3-protein
was added to the solution bathing either the extracellular
side (Fig. 2) or the intracellular side (Fig. 3) of inside-out
excised membrane patches. After the direct incorporation of
A,BP[1-40] molecules from the solution, which was re-
vealed by the appearance of channel activity, Zn2+ was
added to the chamber facing the inner aspect of the patch.
Fig. 2 shows the activity of the A,BP[1-40] channel
(Af3P[1-40] in the pipette). Traces represent segments of a
continuous record of A,BP channel activity recorded at dif-
ferent transmembrane potentials in the absence (top) and in
the presence (bottom) of Zn2+. In the absence of Zn2+,
regardless of the direction of the Cs+ current, channel
activity is rather irregular. At -40 mV, Cs+ is expected to
flow through the open channel from the bath to the pipette
(upper left), and in the opposite direction at 40 mV (upper
right). A few minutes after the addition of Zn+ (250 ,uM) to
the solution facing the cytoplasmic aspect of the membrane
patch, channel activity was profoundly inhibited (bottom). It
should be noted that the extent of the blockade induced by
Zn2+ depends on the direction of the Cs+ flow. Indeed,
while at a pipette potential of -40 mV, there is an almost
complete inhibition in the A,BP[1-40] channel activity (Fig.
2, lower left). In contrast, at 40 mV, for a substantial
fraction of time, there is channel activity expressed as
well-defined events (Fig. 2, lower right). Because these
records were made at a positive potential inside of the
pipette, the electrical potential gradient should drive Cs+
ions through the open channel. It is then possible that Cs+
flowing along the pore, from the external side of the mem-
brane, might displace Zn2+ from binding sites at the cyto-
plasmic end of the pore. In addition, before the application
of Zn2+, the fractional open time of the A,BP[1-40] channel
remained at -0.9, even though the transmembrane potential
was changed from -40 mV to 40 mV (Fig. 2, top). By
contrast, in the presence of Zn2+ (s250 ,uM), the fractional
open time changed from -0.05 at -40 mV (Fig. 2, lower
left) to -0.17 at 40 mV (Fig. 2, lower right).
From these data we conclude that the A,3P[1-40] mole-
cule can insert itself into the plasma membrane from the
solution on the extracellular side. Because Zn2+ applied
from the intracellular side can modulate the channel, the
unavoidable conclusion is that A,3P[1-40] molecules form-
ing the channel (Durell et al., 1994) can span the hydropho-
bic region of natural membranes, making it possible for the
transition element to interact with the channel from the
intracellular side.
Zn2+ blockade is reversed by o-phenanthroline
We also studied the specificity of the interactions between
Zn2+ and amyloid ,3-protein channels incorporated directly
from the solution into the cytoplasmic side of the patch. In
the symmetrical CsCl solution system, the potential across
the patch was set at -20 mV, and a few minutes after the
addition of the protein A,BP[1-40] to the bath (4.7 ,tM),
channel activity began (Fig. 3, left). Because the character-
istic multilevel channel activity was observed, we con-
cluded that incorporation of the amyloid 13-protein had
occurred (Fig. 3, left). Amplitude histograms of the activity
revealed the multilevel character of the channel activity
with the following levels: 1.0, 1.7, 2.6, 4.1, 5.9, 9.3, and
12.8 pA (not shown). Furthermore, exposure of the cyto-
incorporated from the extracellular side of the patch
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FIGURE 2 Addition of Zn2+ to the bath blocks the AP3P[1-40]-channel incorporated from the solution in the pipette. (Top) Two sets of ten segments
of a continuous current record made in the absence of Zn2+, at -40 mV (left) and 40 mV (right), respectively. (Bottom) Two sets of 10 segments of a
continuous current record made after the addition of Zn2+ (250 ,uM) to the bath at -40 mV (left) and 40 mV (right), respectively.
marked reduction of the amplitude of the channel current
(Fig. 3, center). In the presence of Zn2+, transitions between
three tiny levels of channel current (0.69, 1.0, and 1.85 pA)
occurred at a high frequency (Fig. 3, center), suggesting
brief dissociations between the Zn2+ and the A(3P[l-40]
channel. These profound changes in the AB3P[l-40] channel
gating induced by Zn2+ led us to consider the possibility
that Zn2+ might stabilize a few conformations of the
A3P[1-40] aggregate forming the hypothetical pore (Durell
et al., 1994). It should be mentioned here that these effects
of Zn2+ on A,3P[I-40] channel activity incorporated into
neuronal membranes are similar to those observed in the
artificial bilayer (Arispe et al., 1996). Finally, the addition
of o-phenanthroline (2 mM), a specific Zn2+ chelator, ef-
fectively removed the free Zn2+, leading to the recovery of
the AfBP[1-40] channel currents (Fig. 3, right). Amplitude
histograms showed the following levels: 1.1, 1.7, 2.5, 3.9,
6.0, 8.8, and 12.8 pA. It should be noted that these levels
follow the "3/2 rule" for channels with multilevels of con-
ductance (Pollard et al., 1994).
Experiments in which A(P[1-40] was incorporated from
the extracellular side of the patch, and Zn2+ was added to
the bath facing the intracellular side of the patch, also
showed the interactions between the channel and the tran-
sition element. The analysis of the A,BP[1-40] channel
activity recorded in the presence of Zn2+ revealed the
occurrence of brief transitions between different single-
channel current levels. Indeed, the four segments of a con-
tinuous record acquired at 40 mV shown in Fig. 4 on an
expanded time base show brief closures of the Af3P[1-40]
induced by Zn2+. It is apparent that the transitions also
occurred between consecutive levels. It should not be for-
gotten that in the absence of divalent cations, A/3P[l-40]
channel gating is rather insensitive to the transmembrane
potential (Fig. 1). By contrast, the frequency of the transi-
tions between different levels (Fig. 4, top) changed at dif-
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FIGURE 3 Direct incorporation of A(3P[I-40] from the intracellular
side of the membrane patch. (Left) Ten consecutive records of the A,BP[1-
40] channel activity at -20 mV. (Center) Ten consecutive records of the
A,BP[1-40] channel activity at -20 mV after the exposure of the intracel-
lular aspect of the membrane patch to Zn2+ (250 ,M) added to the bath
solution. (Right) Records were made at -20 mV a few minutes after the
addition of o-phenanthroline (2 mM) to the bath.
ferent transmembrane potentials. For example, the frac-
tional open time at the smallest level (i.e., -0.69 pA; Fig. 4,
top) decreased from 0.7 (at 40 mV) to 0.4 at 10 mV.
Identification of Aj3P[1-40] deposition by
confocal immunocytochemical microscopy
To determine whether A,BP[1-40] can also interact with the
membrane of viable GT1-7 neurons and to gather informa-
tion on the localization of the A,BP[1-40] molecules, we
used two specific antibodies, one raised against a neuronal
marker (MAP2) and the other against A,BP[1-40]. As
shown in the confocal micrographs depicted in Fig. 5, both
antibodies reacted with the target proteins, demonstrating
the deposition of aggregates of A,BP[1-40] on the surface of
a substantial fraction of the cultured GT1-7 cells. It is also
apparent that whereas MAP2 (pseudocolor green) is homo-
geneously distributed on the cell bodies and along the cell
branches and processes, the amyloid ,B-protein marker cov-
ers only some areas on the surface of the neurons. Although
it is impossible to determine the exact neuronal target struc-
ture with the resolution at hand (pseudocolors red-yellow),
in enlarged images of selected zones of the plated GT1-7
cells, the density of the A,3P[1-40] mark is higher than that
of MAP (Fig. 5 B) and is by far less homogeneous (Fig. 5
A). It is possible that discrete areas of the GT1-7 cells are
more susceptible to the deposition of amyloid 3-protein.
DISCUSSION
The data presented here provide compelling evidence sup-
porting the idea that free A,BP[1-40] molecules in solution
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FIGURE 4 Multilevel A,BP[1-40]-channel activity during Zn2+ evoked
blockade. A,BP[1-40] was added to the solution in the pipette (-4.7 ,uM).
Zn2+ was added to the solution in the bath (250 PM). (Top) Records were
made at 40 mV. Horizontal lines indicate the current level (numbers on the
right side in pA) calculated using the "3/2 rule" (Pollard et al., 1994).
(Bottom) Open-time distribution. The fitted curve was calculated with two
time constants, 2.5 and 11.6 ms.
can spontaneously interact with the plasma membrane of
GnRH neurons to form cation-selective channels. Further-
more, channel formation occurs when AJ3P[1-40] is present
in the saline bathing either the intracellular or the extracel-
lular aspect of the cell membrane. The characteristics of the
A,BP[I-40] channel activity in the natural membrane are
rather similar to those described before in artificial lipid
bilayers (Arispe et al., 1993a,b, 1996). By contrast, mem-
brane patches remained electrically silent after exposure to
the peptide AP3P[40-1] with the reverse amino acid se-
quence for a period of 60 min. Thus it is possible that the
peptide A,BP[1-40] in solution can acquire a specific con-
formation that allows the incorporation of the protein to
form the channel.
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FIGURE 5 Immunocytochemical
identification and localization of the
AP3P[I-40] in GnRH neurons. Confocal
fluorescence microscopy of cultured
GTl-7 after a,342 binding (FITC fluo-
rescence) followed by MAP2 binding
(Texas red fluorescence). For contrast,
red fluorescence from MAP2 was
changed to green by using pseudocolor
software.
25jm
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We have also shown here that Zn2+ interacts with spe-
cific domains of the A,3P[1-40] molecules incorporated
into the excised membrane patch, leading to blockade of the
channel. This blockade of the A,3[1-40] channel occurs
even when the transition element is added to the intracel-
lular side (bath solution) and the channel protein is added to
the extracellular side of the membrane patch. This result
strongly suggests that the A,3P[1-40] molecules incorpo-
rated into the membrane can span the entire membrane.
We have previously proposed that channel formation
requires the aggregation of several A,BP[1-40] molecules
(Durell et al., 1994). Thus the marked decrease in A,BP[1-
40] channel current induced by the addition of Zn2+ on the
cytoplasmic side of the excised membrane patch (Figs. 2
and 3) suggests that Zn2+ ions present in the solution can
interact with specific domains of the A/3P[I-40] molecules
forming the pore. Thus Af3P[l-40]/Zn2+ interactions can
occur, despite the fact that the amyloid ,3-protein has been
incorporated from the extracellular side (Fig. 2). Low-affin-
ity association between Zn2+ and the ABP[I1-40] channel
could explain the fast blocking events (as depicted in Fig.
4). It is also possible that the low-affinity binding of Zn2+
to A,BP[1-40] sites may induce rapid rearrangements of the
molecules forming part of the channel aggregate (Durell et
al., 1994). These conformational changes might in turn
cause the observed flickering of the current. However, the
lOJm
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open time of the AJ3P[1-40] channel was found to be rather
insensitive to the transmembrane potential under calcium-
deficient conditions (Fig. 1). Thus voltage-dependent
A,BP[1-40] channel gating (Fig. 4, top) can be observed
only under conditions that allow divalent cations, such as
Ca2+ (Arispe et al., 1993b) and Zn2+ (this work), to enter
the channel pore (Durell et al., 1994) and interact with
specific binding sites. On the basis of our molecular model
(Durell et al., 1994), we conclude that Zn2+/A13P[1-40]
interactions must occur in a high dielectric constant region,
probably at the entrance of the A,BP[1-40] channel, where
the electric field can be assumed to be relatively constant.
Application of o-phenanthroline induced a complete re-
covery of the control A(3P[1-40] channel activity, which
was characterized by infrequent transitions among different
levels of conductance (not shown). It should be mentioned
here that o-phenanthroline can remove the blockade only if
applied to the side containing Zn2+. These results are in
good agreement with recently published planar lipid bilayer
data (Arispe et al., 1996).
In conclusion, our channel data indicate that A,BP[1-40]
molecules in solution can interact with both the external as
well as the internal aspect of the plasma membrane and
form cation-selective channels. The addition of Zn2+ to the
bath solution (cytoplasmic side of the patch) blocked the
multilevel A,BP[1-40] channel activity, regardless of the
side of incorporation of the Af3P[1-40] molecules. This
result suggests that Zn2+ can block the flow of Cs+ through
the open channel from either end of the pore.
Finally, our preliminary immunocytochemical analysis
showed that whereas the neuronal membrane marker MAP2
was homogeneously localized throughout the cell bodies
and dendritic tree, the antibody ca342 reacted with amyloid
13-protein molecules deposited onto restricted regions of the
cell bodies and processes (Fig. 5 B). Although we do not
have an explanation for this remarkable difference in the
localization of the two antibodies, it is possible that discrete
membrane areas of the GT1-7 cells are more susceptible to
the deposition of amyloid 1-protein. In this respect, it is not
uncommon to find in different types of neurons specialized
membrane regions containing distinct membrane proteins.
For example, immunolocalization studies in Purkinje neu-
rons revealed a rather homogeneous localization of ryano-
dine and inositol 1,4,5-triphosphate (1P3) receptor proteins
throughout the cell body and dendritic tree. By contrast, IP3
receptors were detected only in the dendritic spines (Ellis-
man et al., 1990, 1991; Martone et al., 1993; Sharp et al.,
1993).
Taken together, the results presented here suggest that the
interactions between amyloid 13-protein and neuronal mem-
branes also occur in vivo, lending further support to the idea
that A13P[1-40] channel formation might be a mechanism
of amyloid 13-protein neurotoxicity (Arispe et al., 1994).
The interactions of Zn2+ with amyloid 13-protein molecules
incorporated into neuronal membranes could even lead to
attenuation of amyloid channel neurotoxicity. It should also
be mentioned here that the concentration of amyloid 13-pro-
tein used in this work was higher than the levels detected in
cerebrospinal fluid (CSF) samples from normal and Alzhei-
mer's patients (Seubert et al., 1992). However, analysis of
CSF in samples from these subjects showed identical con-
centrations of soluble A,BP[1-40] (i.e., <1 ,tM) in both
groups (Tabaton et al., 1994), suggesting that the presence
of soluble amyloid P-protein in the CSF cannot be consid-
ered a marker of the disease.
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